Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) represents the
malignant counterpart derived from plasmacytoid dendritic cells. This rare entity is usually …

Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease
characterized by malignant proliferation of a contingent blastic plasmacytoid dendritic cell …

Aim. Blastic plasmacytoid dendritic cell neoplasm (BPDNC) is a rare tumour, which stems
from plasmacytoid dendritic cells. Although the aetiology is still unclear, in the last few years …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive
hematological malignancy derived from precursors of plasmacytoid dendritic cells. This …

Blastic plasmacytoid dendritic cell neoplasm is a rare clinicopathologic entity, characterized
by strong skin tropism and a poor prognosis. The diagnosis is generally made by skin biopsy …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy
derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course …

Rationale: Blastic plasmacytoid dendritic cell neoplasm (BPDCN), derived from precursors
of plasmacytoid dendritic cells, is a rare and aggressive malignancy with frequent cutaneous …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy
with an aggressive clinical course. It is grouped with acute myeloid leukemia–related …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an exceedingly rare disorder
categorized under acute myeloid leukemia by the World Health Organization …

Overall, biologists and pathologists need to be alert to the diagnosis of BPDCN, and they
should learn to recognize its characteristics. Because it is rare and depends on recognition …